These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2534934)

  • 1. Huntington's disease: studies with structural imaging techniques and positron emission tomography.
    Mazziotta JC
    Semin Neurol; 1989 Dec; 9(4):360-9. PubMed ID: 2534934
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography imaging of dopamine and serotonin receptors in Huntington's chorea.
    Wong DF; Wagner HN; Links JM; Dannals RF; Folstein S; Ravert HT; Tune L; Pearlson G; Frost JJ; Folstein M
    Am J Physiol Imaging; 1988; 3(1):51. PubMed ID: 2968808
    [No Abstract]   [Full Text] [Related]  

  • 3. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.
    Reid IC; Besson JA; Best PV; Sharp PF; Gemmell HG; Smith FW
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1264-8. PubMed ID: 2976081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging and dementia.
    Benson DF
    Neurol Clin; 1986 May; 4(2):341-53. PubMed ID: 2940453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET.
    Andrews TC; Brooks DJ
    Mol Med Today; 1998 Dec; 4(12):532-9. PubMed ID: 9866823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peek inside the Huntington's brain: will functional imaging take us one step closer in solving the puzzle?
    Georgiou-Karistianis N
    Exp Neurol; 2009 Nov; 220(1):5-8. PubMed ID: 19679124
    [No Abstract]   [Full Text] [Related]  

  • 8. Computed tomography in the diagnosis of Huntington's disease.
    Lee CC; Chen ST; Lu CS; Hsi MS
    Changgeng Yi Xue Za Zhi; 1986 Sep; 9(3):157-64. PubMed ID: 2970288
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.
    Holthoff VA; Koeppe RA; Frey KA; Penney JB; Markel DS; Kuhl DE; Young AB
    Ann Neurol; 1993 Jul; 34(1):76-81. PubMed ID: 8390806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cerebral function with positron computed tomography.
    Phelps ME; Mazziotta JC; Huang SC
    J Cereb Blood Flow Metab; 1982; 2(2):113-62. PubMed ID: 6210701
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular Imaging of Huntington's Disease.
    Ciarmiello A; Giovacchini G; Giovannini E; Lazzeri P; Borsò E; Mannironi A; Mansi L
    J Cell Physiol; 2017 Aug; 232(8):1988-1993. PubMed ID: 27791273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New techniques for understanding Huntington's disease.
    Hurley RA; Jackson EF; Fisher RE; Taber KH
    J Neuropsychiatry Clin Neurosci; 1999; 11(2):173-5. PubMed ID: 10333989
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between CT scan changes and the duration of illness in Huntington's chorea (author's transl)].
    Konagaya M; Mukai E; Murakami N; Muroga T; Sobue I
    Rinsho Shinkeigaku; 1980 Feb; 20(2):113-20. PubMed ID: 6445252
    [No Abstract]   [Full Text] [Related]  

  • 15. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
    Leenders KL; Frackowiak RS; Quinn N; Marsden CD
    Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset Huntington's chorea. Diagnostic clues.
    Brooks DS; Murphy D; Janota I; Lishman WA
    Br J Psychiatry; 1987 Dec; 151():850-2. PubMed ID: 2971414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single photon emission computed tomography in subjects at risk for Huntington's chorea.
    Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E
    J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077
    [No Abstract]   [Full Text] [Related]  

  • 19. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel DS; Berent S; Giordani B; Ehrenkaufer R; Jewett D; Hichwa R
    Ann Neurol; 1986 Sep; 20(3):296-303. PubMed ID: 2945510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease in a Coloured family.
    Saffer DS; Nathan DC; Kahle PA; Steingo B
    S Afr Med J; 1974 Nov; 48(58):2399-402. PubMed ID: 4279450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.